Acute myelomonocytic leukemia
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Acute myelomonocytic leukemia (AMMoL) is a form of acute myeloid leukemia which involves a proliferation of CFU-GM myeloblasts and monoblasts.
It is classified under “M4” in the French-American-British classification (FAB).[1]
It is classified under “AML, not otherwise classified” in the WHO classification.[2]
Translocations have been observed.[3]
Progression from myelodysplastic syndrome has been reported.[4]
See also
References
- ↑ “Acute Myeloid Leukemia – Signs and Symptoms”.
- ↑ “eMedicine – Acute Myelogenous Leukemia : Article by Karen Seiter”.
- ↑ Yamamoto K, Nagata K, Tsurukubo Y; et al. (2002). “Translocation (8;12)(q13;p13) during disease progression in acute myelomonocytic leukemia with t(11;19)(q23;p13.1)”. Cancer Genet. Cytogenet. 137 (1): 64–7. PMID 12377416.
- ↑ Zhang L, Alsabeh R, Mecucci C; et al. (2007). “Rare t(1;11)(q23;p15) in therapy-related myelodysplastic syndrome evolving into acute myelomonocytic leukemia: a case report and review of the literature”. Cancer Genet. Cytogenet. 178 (1): 42–8. doi:10.1016/j.cancergencyto.2007.06.012. PMID 17889707.
External links
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH